ProCE Banner Activity

Immunotherapy in Urothelial Bladder Cancer: Updates in Metastatic Disease

Slideset Download
In this downloadable slideset, Elizabeth R. Plimack, MD, MS, explores the current clinical data on the use of immune checkpoint inhibitor-based therapy for patients with metastatic urothelial carcinoma.

Released: November 07, 2019

Expiration: November 05, 2020

No longer available for credit.

Share

Faculty

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genentech TEXT Only

Program Director Disclosure

Program Director

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania